US Retina Market Quarterly Updates
|出版商||Market Scope, LLC||商品編碼||644709|
|美國的視網膜治療市場:季報 US Retina Market Quarterly Updates|
|出版日期: 4 Issues/Year||內容資訊: 英文||
本報告提供美國的視網膜治療市場上主要標準相關分析，治療藥 (Lucentis，Eylea，Avastin)的使用，IVT (玻璃體內注射) 注射，DME (糖尿病黃斑部水腫)的治療，皮質類固醇的使用，光凝固手術數量和光凝固設備的使用，玻璃體切除數量和定位，拋棄式手術用套件等相關彙整。
We collect data on a quarterly basis from US retina specialists on a range of practice of medicine and practice management issues. We began this survey process in 2008. The data we collect are analyzed and presented in our US Retina Quarterly Updates.
New in 2019 - focus on next-gen vitrectomy machine features and newly approved IVTs, and adoption plans for genetic screening.
Market Scope has been surveying United States ophthalmologists quarterly for over 20 years. The resulting data are analyzed and presented in our Quarterly Update Reports.
This update is designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends. Each update includes full-year forecasts, comparisons with prior years, and trend analysis.
Every quarter, Market Scope surveys 3,500+ doctors from all specialties in order to produce these updates. We survey on procedure volumes, pricing and fees, product preferences, treatment plans, adoption of new technologies, and much more.
Beyond survey data, Market Scope sources additional information from our proprietary disease models, database of refractive and cataract specialists, primary research, and public data sources. In some cases, this additional information is used to extrapolate survey data to total market estimates.